In addition, higher SOX2 levels have been reported to correlate with poorer prognosis in cancers, such as breast, colorectal, oesophageal, ovarian, prostate, and lung cancer as well as in nasopharyngeal and sinonasal carcinoma32,33,35–42. The gene discussed is SOX2; the disease is lung cancer.